Dr. Dolly Mehta's lab at the University of Illinois at Chicago focuses on understanding and treating acute lung injuries, which are often caused by infections. The research examines how certain cells in the lungs, particularly macrophages and endothelial cells, behave during inflammation and injury. By studying these cells' mechanisms, the lab aims to develop targeted therapies that protect lung function and promote healing during acute respiratory distress syndrome.

Dr. Swetha Gowrishankar's lab at the University of Illinois at Chicago focuses on understanding and treating Alzheimer's disease through a process called autophagy, which helps cells recycle and maintain their health. The lab's goal is to develop small molecules that can improve autophagy and potentially halt disease progression by restoring balance in neuronal environments. This research aims to create innovative therapeutic options that go beyond current treatments, targeting the root causes of cell damage instead of just the symptoms of Alzheimer's.

Dr. Amy Kenter's lab studies how antibodies are formed by exploring the genetic rearrangements that create a diverse set of these crucial immune molecules. By mapping the three-dimensional structure of antibodies' genetic material, the lab aims to understand the factors that influence the selection and efficient use of these antibodies during immune responses. This research contributes to improving vaccine development by enhancing our knowledge of immune system function.

Dr. Paul R Carlier's lab at the University of Illinois at Chicago focuses on developing new drugs to fight malaria, a disease that affects millions worldwide. The lab is optimizing new antimalarial compounds that can target different life stages of the malaria parasite, with the goal of overcoming drug resistance. Students in the lab will learn important laboratory techniques while helping to create treatments that could save lives.

Kamran Avanaki's lab focuses on improving the diagnosis and treatment of hidradenitis suppurativa (HS), a painful skin disease that affects many people. The research involves developing an innovative imaging system that combines photoacoustic and ultrasound technologies to create detailed 3D images of HS lesions. This system aims to enhance clinical assessments, leading to more accurate treatment plans and a better understanding of the disease.

Dr. Jeffrey A Loeb's lab focuses on integrating complex data from the human brain to improve diagnosis and treatment for brain disorders. By creating a unique human brain tissue bank linked with a comprehensive multimodal dataset, the lab aims to advance translational research and enhance clinical care. Their work supports both pediatric and adult populations and emphasizes the importance of fresh brain tissue in discovering new biomarkers and therapeutic targets.

Dr. Andreas A Linninger's research lab focuses on understanding how age and Alzheimer's disease affect blood flow and metabolism in the brain. By using advanced imaging techniques and computational modeling, the lab aims to create detailed simulations linking changes observed in mouse models to conditions in humans. This research seeks to identify biomarkers that could predict cognitive decline and improve diagnostic methods for Alzheimer’s disease.

Dr. Stephanie M Cologna's lab focuses on finding new treatments for Niemann-Pick disease type C1, a severe disorder that affects the body's ability to manage cholesterol and can lead to early death. The lab works on understanding how specific peptides can improve cholesterol storage issues associated with this disease. Through biochemical studies and innovative techniques, the team aims to uncover new therapeutic methods to combat this currently untreatable condition, potentially extending the lives of affected individuals.

Dr. Zaijie Jim Wang's research lab focuses on understanding the molecular mechanisms of chronic pain associated with sickle cell disease (SCD) to develop effective treatments. The lab uses advanced techniques like studying epigenetics and gut microbiota to uncover the biological processes behind this pain. Ultimately, the goal is to improve therapies that help the thousands of patients suffering from chronic pain linked to SCD.

Dr. Konstantinos Chronis's lab focuses on how certain factors can transform cells found in blood vessels into hematopoietic stem cells (HSCs), which are vital for producing blood cells. By understanding this reprogramming process, the lab aims to develop new methods for generating HSCs that could be used in medical treatments. Their research explores the genetic changes that happen during this transformation and how to make the process more efficient and effective for clinical applications.

David Eddington's lab focuses on understanding how the bacterium Streptococcus pneumoniae, a major cause of pneumonia and meningitis, acquires antibiotic resistance through genetic transformation. The lab utilizes microfluidics technology to study bacteria in small environments, enabling detailed examination of how genetic material is exchanged between bacterial cells. By investigating these mechanisms, the lab aims to develop better strategies for combating bacterial infections that have become increasingly resistant to current treatment methods.

Dr. Monica Y Lee's lab at the University of Illinois at Chicago focuses on understanding how endothelial cells, which line blood vessels, respond to blood flow and environmental cues. The lab investigates the role of a specific protein, nucleoporin93 (Nup93), in maintaining vascular health and preventing inflammation that can lead to atherosclerosis. Through their research, they aim to uncover new therapeutic approaches for cardiovascular diseases by exploring how Nup93 signaling affects endothelial function.

Dr. Nancy Elizabeth Freitag's lab studies the bacteria Listeria monocytogenes, which can cause serious infections, especially in pregnant women. The research focuses on understanding how certain strains of this bacterium invade the placenta and affect fetal development. By uncovering the mechanisms behind this infection, the lab aims to improve infection management and maternal-fetal health outcomes.

Maxim Frolov's research lab focuses on understanding how certain pathways in cells control their growth and specialization during animal development. Using the fruit fly Drosophila as a simpler model, the lab studies the Retinoblastoma (RB) and Hippo pathways and their roles in cell cycles and how they can lead to diseases when they malfunction. The goal is to gain insights that can potentially inform treatments for conditions like cancer and other growth-related diseases.

Dr. Chong Wee Liew's research focuses on how the body processes fructose, particularly in brown adipose tissue, which is important for energy regulation and metabolism. His lab is investigating how a high-fructose diet affects the functioning and health of brown fat, and the implications this has for obesity and diseases like type 2 diabetes. By studying the role of specific transporters and gut microbiota, they aim to uncover the mechanisms behind fructose-induced metabolic changes.

Dr. Nissim Hay's lab at the University of Illinois at Chicago focuses on understanding the role of Hexokinase 2 (HK2) in liver fibrosis and liver cancer. The lab investigates how HK2 contributes to the metabolic changes in liver cells during disease and looks for ways to leverage this knowledge for new treatments. Additionally, they explore HK2's role in cancer cell metabolism and its potential as a therapeutic target in various cancers.

The research lab led by Dr. Teruyuki Sano focuses on understanding the behavior and adaptability of innate lymphoid cells (ILCs), which are important immune cells found in mucosal tissues like the intestines. The lab investigates how these cells can change into different types in response to their environment, especially during conditions like infection or inflammation. This research has implications for treating inflammatory diseases and could help in developing new therapies to manage immune responses.

Dr. Salman Khetani's lab at the University of Illinois at Chicago focuses on understanding and treating non-alcoholic fatty liver disease (NAFLD) by studying how different components of the liver's environment influence the behavior of liver cells. The lab creates engineered systems that mimic the liver environment, allowing researchers to discover how changes in cell composition and stiffness affect liver cell function and disease progression. Their ultimate goal is to develop new therapies to combat liver diseases that are becoming increasingly prevalent.

Dr. Jan K. Kitajewski's research lab focuses on understanding how specific signaling pathways influence the formation of blood vessels, a process known as angiogenesis. By investigating the roles of different Notch proteins, particularly Notch4, in vascular biology, the lab aims to uncover new therapeutic strategies to treat conditions like cancer and eye diseases associated with excessive blood vessel growth. The research combines advanced molecular techniques with studies in animal models to explore the implications of these pathways in both healthy and diseased states.

Dr. Ernesto Roque Bongarzone's lab at the University of Illinois at Chicago is focused on developing new therapies for Krabbe disease, a genetic disorder that affects the nervous system. The lab studies various treatment strategies including gene therapy and small molecule inhibitors that could help reduce toxic levels of psychosine, a harmful substance that accumulates in patients with this condition. By improving treatment options, this research aims to enhance the quality of life for individuals affected by Krabbe disease and potentially other related disorders.